R. Dixon Dorand et al. have found that Cdk5 disruption can help outcome tumor medulloblastoma. They published their research results in Science Magazine (Science  22 Jul 2016: Vol. 353, Issue 6297, pp. 399-403 DOI: 10.1126/science.aae0477), and we share this wonderful article here. By the way, Creative Biomart provides kinds of molecular tools to promote your research about tumor therapy. [table caption=”Related Products” width=”800″ colwidth=”80|180|180″ colalign=”left|left|center|center|center”] Cat. #,Product name,Source(Host),Species,Conjugate CDK5-3204M,Recombinant Mouse CDK5 Protein,Mammalian…